Dr. Catherine A. Cukras

Peter A. Campochiaro, M.D. is the George S. and Dolores Doré Eccles Professor of Ophthalmology and Neuroscience at the Wilmer Eye Institute, Johns Hopkins University School of Medicine. He is a clinician-scientist who directs a research laboratory and conducts clinical trials. His laboratory research is directed at understanding the pathogenesis of ocular neovascularization and excessive retinal vascular permeability, and the mechanism of cone cell death in inherited retinal degenerations. He helped to determine the importance of vascular endothelial growth factor (VEGF), hypoxia-inducible factor-1, and Tie2 in retinal and choroidal vascular diseases. The clinical trial group under Dr. Campochairo provided the first demonstration of the benefits of suppression of VEGF in diabetic macular edema and retinal vein occlusion. He has developed strategies for sustained suppression of VEGF that are currently being tested in clinical trials. Dr. Campochiaro trained at the University of Notre Dame, Johns Hopkins School of Medicine, and the University of Virginia. He did a vitreoretinal fellowship and research fellowships at Johns Hopkins and joined the faculty of the University of Virginia in 1984. He became professor of Ophthalmology and Neuroscience at the Wilmer Eye Institute, Johns Hopkins in 1991. Dr. Campochiaro is rated as an Elite provider by MediFind in the treatment of Retinopathy Pigmentary Mental Retardation. His top areas of expertise are Retinal Vein Occlusion, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Trabeculectomy, and Vitrectomy.

Brian Brooks is an Ophthalmologist in Washington, Washington, D.c.. Dr. Brooks is rated as an Elite provider by MediFind in the treatment of Retinopathy Pigmentary Mental Retardation. His top areas of expertise are Coloboma, Albinism, Oculocutaneous Albinism, and Oculocutaneous Albinism Type 1.

Laryssa Huryn is an Ophthalmologist in Washington, Washington, D.c.. Dr. Huryn is rated as a Distinguished provider by MediFind in the treatment of Retinopathy Pigmentary Mental Retardation. Her top areas of expertise are Bietti Crystalline Dystrophy (BCD), Late-Onset Retinal Degeneration, Retinopathy Pigmentary Mental Retardation, and Cone-Rod Dystrophy.